Daryl Wiesen > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
![Goodwin company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/50382.jpg?v=1653298090)
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Daryl Wiesen
![Daryl Wiesen photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/06/Wiesen-248x300.png)
Position
Partner
Career
Daryl Wiesen is a partner and former co-chair of Goodwin’s Intellectual Property Litigation practice and focuses his practice on patent litigation and advising clients in patent portfolio development. He has more than 20 years of experience advising clients and participating in all phases of patent litigation, from initial counseling up through trial and appeal. Daryl has developed an expertise in pharmaceutical patent litigation under the Hatch-Waxman Act, representing both plaintiffs and defendants. He also has experience in other technologies, including biotechnology and medical devices. He represents universities in patent and licensing disputes concerning technology discovered at the universities and then out-licensed to companies for further development.
Education
JD, 1996, Yale Law School / BA, 1993, Brown University (magna cum laude, Phi Beta Kappa)
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism